Peroxisome proliferator-activated receptor gamma overexpression and knockdown: Impact on human B cell lymphoma proliferation and survival

Cancer Immunology, Immunotherapy

Volumn 58, Issue 7, 2009, Pages 1071-1083

  Garcia Bates, Tatiana M ^a   Peslak, Scott A ^a   Baglole, Carolyn J ^a   Maggirwar, Sanjay B ^a   Bernstein, Steven H ^a   Phipps, Richard P ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

B cell lymphoma; Overexpression; PPARgamma; Proliferation; SiRNA

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGENIC AGENT; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN BCL 2;

ARTICLE; B CELL LYMPHOMA; BURKITT LYMPHOMA; CANCER INHIBITION; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; GROWTH DISORDER; HUMAN; HUMAN CELL; LYMPHOMA CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA INTERFERENCE; STIMULUS RESPONSE;

B-CELL-SPECIFIC ACTIVATOR PROTEIN; BURKITT LYMPHOMA; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE KNOCKDOWN TECHNIQUES; GENETIC VECTORS; HUMANS; LIGANDS; NF-KAPPA B; PPAR GAMMA; PROTO-ONCOGENE PROTEINS C-BCL-2; REPRESSOR PROTEINS; RNA INTERFERENCE;

EID: 67349168710     PISSN: 03407004     EISSN: 14320851     Source Type: Journal    
DOI: 10.1007/s00262-008-0625-z     Document Type: Article

References (58)

1. F Akbiyik DM Ray KF Gettings N Blumberg CW Francis RP Phipps 2004 Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes Blood 104 1361 1368 (Pubitemid 39166512)
2. C Arpin J Dechanet C Van Kooten P Merville G Grouard F Briere J Banchereau YJ Liu 1995 Generation of memory B cells and plasma cells in vitro Science 268 720 722
3. BA Beamer C Negri CJ Yen O Gavrilova JM Rumberger MJ Durcan DP Yarnall AL Hawkins CA Griffin DK Burns J Roth M Reitman AR Shuldiner 1997 Chromosomal localization and partial genomic structure of the human peroxisome proliferator activated receptor-gamma (hPPAR gamma) gene Biochem Biophys Res Commun 233 756 759 (Pubitemid 27217726)
4. MV Berridge PM Herst AS Tan 2005 Tetrazolium dyes as tools in cell biology: new insights into their cellular reduction Biotechnol Annu Rev 11 127 152 (Pubitemid 41510276)
5. MA Bouhlel B Derudas E Rigamonti R Dievart J Brozek S Haulon C Zawadzki B Jude G Torpier N Marx B Staels G Chinetti-Gbaguidi 2007 PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties Cell Metab 6 137 143 (Pubitemid 47189091)
6. O Braissant F Foufelle C Scotto M Dauca W Wahli 1996 Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat Endocrinology 137 354 366 (Pubitemid 26005011)
7. D Campana T Suzuki E Todisco A Kitanaka 2000 CD38 in hematopoiesis Chem Immunol 75 169 188 (Pubitemid 30088774)
8. Y Cui J Golob E Kelleher Z Ye D Pardoll L Cheng 2002 Targeting transgene expression to antigen-presenting cells derived from lentivirus-transduced engrafting human hematopoietic stem/progenitor cells Blood 99 399 408 (Pubitemid 34533073)
9. RA Daynes DC Jones 2002 Emerging roles of PPARs in inflammation and immunity Nat Rev Immunol 2 748 759 (Pubitemid 37328715)
10. N Deglon JL Tseng JC Bensadoun AD Zurn Y Arsenijevic L Pereira de Almeida R Zufferey D Trono P Aebischer 2000 Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease Hum Gene Ther 11 179 190 (Pubitemid 30044050)
11. GD Demetri CD Fletcher E Mueller P Sarraf R Naujoks N Campbell BM Spiegelman S Singer 1999 Induction of solid tumor differentiation by the peroxisome proliferator-activated receptor-gamma ligand troglitazone in patients with liposarcoma Proc Natl Acad Sci U S A 96 3951 3956 (Pubitemid 29169017)
12. D Dingli RM Diaz ER Bergert MK O'Connor JC Morris SJ Russell 2003 Genetically targeted radiotherapy for multiple myeloma Blood 102 489 496 (Pubitemid 36841965)
13. C Dresch SL Edelmann P Marconi T Brocker 2008 Lentiviral-mediated transcriptional targeting of dendritic cells for induction of T cell tolerance in vivo J Immunol 181 4495 4506
14. AM Evens LI Gordon 2002 Burkitt's and Burkitt-like lymphoma Curr Treat Options Oncol 3 291 305
15. JA Ferry 2006 Burkitt's lymphoma: clinicopathologic features and differential diagnosis Oncologist 11 375 383
16. S Fujimura J Suzumiya K Nakamura J Ono 1998 Effects of troglitazone on the growth and differentiation of hematopoietic cell lines Int J Oncol 13 1263 1267 (Pubitemid 28551554)
17. Garcia-Bates TM, BA, Phipps RP (2008) Peroxisome proliferator activated receptor gamma (PPARγ) overexpression suppresses growth and induces apoptosis in human multiple myeloma cells. Clin cancer res
18. TM Garcia-Bates GM Lehmann PJ Simpson-Haidaris SH Bernstein PJ Sime RP Phipps 2008 Role of peroxisome proliferator-activated receptor gamma and its ligands in the treatment of hematological malignancies PPAR Res 2008 834612
19. S Ghosh M Karin 2002 Missing pieces in the NF-kappaB puzzle Cell 109 Supp S81 S96
20. CK Glass S Ogawa 2006 Combinatorial roles of nuclear receptors in inflammation and immunity Nat Rev Immunol 6 44 55 (Pubitemid 43279752)
21. CD Gregory C Dive S Henderson CA Smith GT Williams J Gordon AB Rickinson 1991 Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis Nature 349 612 614 (Pubitemid 21912115)
22. R Gugasyan R Grumont M Grossmann Y Nakamura T Pohl D Nesic S Gerondakis 2000 Rel/NF-kappaB transcription factors: key mediators of B cell activation Immunol Rev 176 134 140
23. H Hermeking 2003 The MYC oncogene as a cancer drug target Curr Cancer Drug Targets 3 163 175 (Pubitemid 36565759)
24. N Hirase T Yanase Y Mu K Muta T Umemura R Takayanagi H Nawata 1999 Thiazolidinedione induces apoptosis and monocytic differentiation in the promyelocytic leukemia cell line HL60 Oncology 57 Suppl 2 17 26 (Pubitemid 29494881)
25. T Honda BV Rounds GW Gribble N Suh Y Wang MB Sporn 1998 Design and synthesis of 2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid, a novel and highly active inhibitor of nitric oxide production in mouse macrophages Bioorg Med Chem Lett 8 2711 2714 (Pubitemid 28496657)
26. KK Hristov KA Knox VI Mitev 2005 Regulation of tyrosine phosphorylation during the CD40-mediated rescue of Ramos-BL B cells from BCR-triggered apoptosis Int J Mol Med 16 937 941
27. KM Izumi ED Kieff 1997 The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB Proc Natl Acad Sci USA 94 12592 12597 (Pubitemid 27492573)
28. ES Jaffe J Diebold NL Harris HK Muller-Hermelink G Flandrin JW Vardiman 1999 Burkitt's lymphoma: a single disease with multiple variants. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues Blood 93 1124
29. MD Jumper Y Nishioka LS Davis PE Lipsky K Meek 1995 Regulation of human B cell function by recombinant CD40 ligand and other TNF-related ligands J Immunol 155 2369 2378
30. M Karin Y Ben-Neriah 2000 Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity Annu Rev Immunol 18 621 663 (Pubitemid 30365393)
31. K Katayama K Wada H Miyoshi K Ohashi M Tachibana R Furuki H Mizuguchi T Hayakawa A Nakajima T Kadowaki Y Tsutsumi S Nakagawa Y Kamisaki T Mayumi 2004 RNA interfering approach for clarifying the PPARgamma pathway using lentiviral vector expressing short hairpin RNA FEBS Lett 560 178 182 (Pubitemid 38264314)
32. D Kelly JI Campbell TP King G Grant EA Jansson AG Coutts S Pettersson S Conway 2004 Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-gamma and RelA Nat Immunol 5 104 112 (Pubitemid 38081475)
33. U Klein R Dalla-Favera 2008 Germinal centres: role in B cell physiology and malignancy Nat Rev Immunol 8 22 33
34. M Konopleva E Elstner TJ [tmp] McQueen T Tsao A Sudarikov W Hu WD Schober RY Wang D Chism SM Kornblau A Younes SJ Collins HP Koeffler M Andreeff 2004 Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias Mol Cancer Ther 3 1249 1262 (Pubitemid 39440170)
35. M Konopleva T Tsao P Ruvolo I Stiouf Z Estrov CE Leysath S Zhao D Harris S Chang CE Jackson M Munsell N Suh G Gribble T Honda WS May MB Sporn M Andreeff 2002 Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia Blood 99 326 335
36. Y Lin K Wong K Calame 1997 Repression of c-myc transcription by Blimp-1, an inducer of terminal B cell differentiation Science 276 596 599 (Pubitemid 27193684)
37. ML Martelli R Iuliano I Le Pera I Sama C Monaco S Cammarota T Kroll L Chiariotti M Santoro A Fusco 2002 Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth J Clin Endocrinol Metab 87 4728 4735 (Pubitemid 35247068)
38. C May S Rivella J Callegari G Heller KM Gaensler L Luzzatto M Sadelain 2000 Therapeutic haemoglobin synthesis in beta-thalassaemic mice expressing lentivirus-encoded human beta-globin Nature 406 82 86 (Pubitemid 30460215)
39. E Mueller P Sarraf P Tontonoz RM Evans KJ Martin M Zhang C Fletcher S Singer BM Spiegelman 1998 Terminal differentiation of human breast cancer through PPAR gamma Mol Cell 1 465 470 (Pubitemid 128378895)
40. L Nagy P Tontonoz JG Alvarez H Chen RM Evans 1998 Oxidized LDL regulates macrophage gene expression through ligand activation of PPARgamma Cell 93 229 240 (Pubitemid 28180856)
41. J O'Neil AT Look 2007 Mechanisms of transcription factor deregulation in lymphoid cell transformation Oncogene 26 6838 6849 (Pubitemid 47585107)
42. J Padilla K Kaur HJ Cao TJ Smith RP Phipps 2000 Peroxisome proliferator activator receptor-gamma agonists and 15-deoxy-Delta(12, 14)(12, 14)-PGJ(2) induce apoptosis in normal and malignant B-lineage cells J Immunol 165 6941 6948 (Pubitemid 32001165)
43. J Padilla E Leung RP Phipps 2002 Human B lymphocytes and B lymphomas express PPAR-gamma and are killed by PPAR-gamma agonists Clin Immunol 103 22 33 (Pubitemid 34478417)
44. A Panwalkar S Verstovsek F Giles 2004 Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies Cancer 100 1578 1589 (Pubitemid 38456332)
45. G Pascual AL Fong S Ogawa A Gamliel AC Li V Perissi DW Rose TM Willson MG Rosenfeld CK Glass 2005 A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma Nature 437 759 763 (Pubitemid 41486547)
46. G Pascual CK Glass 2006 Nuclear receptors versus inflammation: mechanisms of transrepression Trends Endocrinol Metab 17 321 327 (Pubitemid 44397567)
47. R Piva P Gianferretti A Ciucci R Taulli G Belardo MG Santoro 2005 15-Deoxy-delta 12, 14-prostaglandin J2 induces apoptosis in human malignant B cells: an effect associated with inhibition of NF-kappa B activity and down-regulation of antiapoptotic proteins Blood 105 1750 1758 (Pubitemid 40223699)
48. XF Qin DS An IS Chen D Baltimore 2003 Inhibiting HIV-1 infection in human T cells by lentiviral-mediated delivery of small interfering RNA against CCR5 Proc Natl Acad Sci USA 100 183 188 (Pubitemid 36078049)
49. DM Ray F Akbiyik SH Bernstein RP Phipps 2005 CD40 engagement prevents peroxisome proliferator-activated receptor gamma agonist-induced apoptosis of B lymphocytes and B lymphoma cells by an NF-kappaB-dependent mechanism J Immunol 174 4060 4069 (Pubitemid 40395982)
50. DM Ray F Akbiyik RP Phipps 2006 The peroxisome proliferator-activated receptor gamma (PPARgamma) ligands 15-deoxy-Delta12, 14-prostaglandin J2 and ciglitazone induce human B lymphocyte and B cell lymphoma apoptosis by PPARgamma-independent mechanisms J Immunol 177 5068 5076 (Pubitemid 44527577)
51. B Rayet C Gelinas 1999 Aberrant rel/nfkb genes and activity in human cancer Oncogene 18 6938 6947
52. JC Reed 2008 Bcl-2-family proteins and hematologic malignancies: history and future prospects Blood 111 3322 3330
53. H Sasaki M Tanahashi H Yukiue S Moiriyama Y Kobayashi Y Nakashima M Kaji M Kiriyama I Fukai Y Yamakawa Y Fujii 2002 Decreased perioxisome proliferator-activated receptor gamma gene expression was correlated with poor prognosis in patients with lung cancer Lung Cancer 36 71 76 (Pubitemid 34224898)
54. K Setoguchi Y Misaki Y Terauchi T Yamauchi K Kawahata T Kadowaki K Yamamoto 2001 Peroxisome proliferator-activated receptor-gamma haploinsufficiency enhances B cell proliferative responses and exacerbates experimentally induced arthritis J Clin Invest 108 1667 1675 (Pubitemid 33144877)
55. AL Shaffer KI Lin TC Kuo X Yu EM Hurt A Rosenwald JM Giltnane L Yang H Zhao K Calame LM Staudt 2002 Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program Immunity 17 51 62
56. DS Straus G Pascual M Li JS Welch M Ricote CH Hsiang LL Sengchanthalangsy G Ghosh CK Glass 2000 15-deoxy-delta 12, 14-prostaglandin J2 inhibits multiple steps in the NF-kappa B signaling pathway Proc Natl Acad Sci USA 97 4844 4849
57. Y Tabe M Konopleva Y Kondo R Contractor T Tsao S Konoplev Y Shi X Ling JC Watt Y Tsutsumi-Ishii A Ohsaka I Nagaoka JP Issa SC Kogan M Andreeff 2007 PPARgamma-active triterpenoid CDDO enhances ATRA-induced differentiation in APL Cancer Biol Ther 6 1967 1977
58. S Theocharis H Kanelli E Politi A Margeli C Karkandaris T Philippides A Koutselinis 2002 Expression of peroxisome proliferator activated receptor-gamma in non-small cell lung carcinoma: correlation with histological type and grade Lung Cancer 36 249 255 (Pubitemid 34497122)